Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Net Income (2024 - 2025)

Historic Net Income for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to $1.8 million.

  • Neuphoria Therapeutics' Net Income rose 19345.74% to $1.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$12.0 million, marking a year-over-year decrease of 34063.73%. This contributed to the annual value of -$6.6 million for FY2025, which is 5711.94% up from last year.
  • Neuphoria Therapeutics' Net Income amounted to $1.8 million in Q4 2025, which was up 19345.74% from -$9.9 million recorded in Q3 2025.
  • Neuphoria Therapeutics' 5-year Net Income high stood at $11.3 million for Q1 2025, and its period low was -$15.2 million during Q2 2025.